Cancer immunotherapy: Moving beyond checkpoint inhibition

Marianne Boes

doi:10.18632/oncotarget.26384

Cancer immunotherapy: Moving beyond checkpoint inhibition

Research output: Contribution to journal › Editorial › Academic › peer-review

2 Downloads (Pure)

Original language	English
Pages (from-to)	36545-36546
Number of pages	2
Journal	Oncotarget
Volume	9
Issue number	93
DOIs	https://doi.org/10.18632/oncotarget.26384
Publication status	Published - 27 Nov 2018

Keywords

Cancer
Cytotoxic
Immunogenicity
Immunotherapy
MHC

Access to Document

10.18632/oncotarget.26384Licence: CC BY

26384-1016231-4-PBFinal published version, 685 KBLicence: CC BY

Cite this

@article{2e3f6fa2161c40f1b55a0e6ea2ca4d52,

title = "Cancer immunotherapy: Moving beyond checkpoint inhibition",

keywords = "Cancer, Cytotoxic, Immunogenicity, Immunotherapy, MHC",

author = "Marianne Boes",

year = "2018",

month = nov,

day = "27",

doi = "10.18632/oncotarget.26384",

language = "English",

volume = "9",

pages = "36545--36546",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "93",

}

TY - JOUR

T1 - Cancer immunotherapy

T2 - Moving beyond checkpoint inhibition

AU - Boes, Marianne

PY - 2018/11/27

Y1 - 2018/11/27

KW - Cancer

KW - Cytotoxic

KW - Immunogenicity

KW - Immunotherapy

KW - MHC

UR - https://www.scopus.com/pages/publications/85063336972

U2 - 10.18632/oncotarget.26384

DO - 10.18632/oncotarget.26384

M3 - Editorial

C2 - 30564293

SN - 1949-2553

VL - 9

SP - 36545

EP - 36546

JO - Oncotarget

JF - Oncotarget

IS - 93

ER -

Cancer immunotherapy: Moving beyond checkpoint inhibition

Keywords

Access to Document

Other files and links

Cite this